Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

ED-71 promotes bone formation and blocks bone resorption in mice

March 11, 2005

Promising findings for VNS Therapy in bulimia nervosa

March 10, 2005

In vivo efficacy of combined warfarin/probucol therapy for steroid-induced osteonecrosis

March 10, 2005

HEALOS(R)-MP52 advantageous in treating long bone defects

March 10, 2005

Janssen researchers describe a series of selective androgen receptor modulators

March 9, 2005

Scientists at Sigma-Tau report the discovery of novel glucose/lipid lowering agents

March 9, 2005

Novel hormone-sensitive lipase inhibitors synthesized by Novo Nordisk

March 9, 2005

Theratechnologies disclose novel GLP-1 receptor ligands for diabetes

March 8, 2005

Three-month results from Progenta uterine fibroid study

March 8, 2005

Alliance and Leo amend Oxygent exclusivity agreement

March 8, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...